Evidence map›Paper›PMID 36130212›Full record

SynthesisHuman molecular genetics2023

Tissue- and cell-specific whole-transcriptome meta-analysis from brain and retina reveals differential expression of dystrophin complexes and new dystrophin spliced isoforms.

César García-Cruz, Jorge Aragón, Sophie Lourdel, Ahrmad Annan, Jérôme E Roger, Cecilia Montanez, Cyrille Vaillend

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Human molecular genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Reading skills over time among children with Duchenne muscular dystrophy.Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence · 2025
    Article
  15. Article
  16. Review
  17. The behavioural consequences of dystrophinopathy.Disease models & mechanisms · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

César García-CruzDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, 07360 Ciudad de México, Mexico.
Jorge AragónDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, 07360 Ciudad de México, Mexico.
Sophie LourdelInstitut des Neurosciences Paris Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.
Ahrmad AnnanInstitut des Neurosciences Paris Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.
Jérôme E RogerInstitut des Neurosciences Paris Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.
Cecilia MontanezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, 07360 Ciudad de México, Mexico.
Cyrille VaillendInstitut des Neurosciences Paris Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.ORCID 0000-0002-8783-8185
Centre National de la Recherche Scientifique · FRInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The large DMD gene encodes a group of dystrophin proteins in brain and retina, produced from multiple promoters and alternative splicing events. Dystrophins are core components of different scaffolding complexes in distinct cell types. Their absence may thus alter several cellular pathways, which might explain the heterogeneous genotype-phenotype relationships underlying central comorbidities in Duchenne muscular dystrophy (DMD). However, the cell-specific expression of dystrophins and associated proteins (DAPs) is still largely unknown. The present study provides a first RNA-Seq-based reference showing tissue- and cell-specific differential expression of dystrophins, splice variants and DAPs in mouse brain and retina. We report that a cell type may express several dystrophin complexes, perhaps due to expression in separate cell subdomains and/or subpopulations, some of which with differential expression at different maturation stages. We also identified new splicing events in addition to the common exon-skipping events. These include a new exon within intron 51 (E51b) in frame with the flanking exons in retina, as well as inclusions of intronic sequences with stop codons leading to the presence of transcripts with elongated exons 40 and/or 41 (E40e, E41e) in both retina and brain. PCR validations revealed that the new exons may affect several dystrophins. Moreover, immunoblot experiments using a combination of specific antibodies and dystrophin-deficient mice unveiled that the transcripts with stop codons are translated into truncated proteins lacking their C-terminus, which we called N-Dp427 and N-Dp260. This study thus uncovers a range of new findings underlying the complex neurobiology of DMD.

Indexed as

DystrophinMuscular Dystrophy, DuchenneAnimalsBrainCodon, TerminatorMiceProtein IsoformsRetinaTranscriptomeCodon, TerminatorDystrophinProtein Isoforms

Identifiers

PMID36130212
PMCPMC9896479
OpenAlexW4296704379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.